Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 11 September 2007. doi:10.1136/adc.2007.119545
Archives of Disease in Childhood - Fetal and Neonatal Edition 2008;93:F58-F63
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

REVIEWS

Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up

K J Rademaker1, L S de Vries1, C S P M Uiterwaal2, F Groenendaal1, D E Grobbee2, F van Bel1

1 Department of Neonatology, University Medical Center Utrecht/Wilhelmina Children’s Hospital, Utrecht, The Netherlands
2 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands

Dr K J Rademaker, Department of Neonatology, KE 04.123.1, University Medical Center Utrecht/Wilhelmina Children’s Hospital, PO Box 85090, 3508 AB Utrecht, The Netherlands; k.rademaker{at}umcutrecht.nl

ABSTRACT

The benefits versus the risks of postnatal administration of steroids in preterm-born infants are still debatable. This review examines the literature on postnatal hydrocortisone treatment for chronic lung disease (CLD) in preterm-born infants with a particular focus on the effects of such treatment on long-term neurodevelopmental outcomes. Quantitative published evidence does not point to a clear advantage of treatment with hydrocortisone over dexamethasone with regard to the impact on long-term neurological outcomes. However, in the absence of a randomised comparison, a consensus may soon have to be reached on the basis of the best available evidence whether hydrocortisone should replace dexamethasone in the treatment of CLD.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Cambonie, G, Mesnage, R, Milesi, C, Rideau, A, Veyrac, C, Picaud, J-C (2009). Hydrocortisone treatment for severe evolving bronchopulmonary dysplasia and cerebral haemodynamics. Arch. Dis. Child. Fetal Neonatal Ed. 94: F154-F155 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs